These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 6349538

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Results of phase III study of lentinan].
    Taguchi T, Furue H, Kimura T, Kondo T, Hattori T, Itoh I, Ogawa N.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):366-78. PubMed ID: 3918510
    [Abstract] [Full Text] [Related]

  • 6. [TS-1 and lentinan combination immunochemotherapy for advanced or recurrent gastric cancer: a preliminary report].
    Kimura Y, Iijima S, Kato T, Tsujie M, Naoi Y, Hayashi T, Tanigawa T, Yamamoto H, Kurokawa E, Matsuura N, Kikkawa N.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1791-3. PubMed ID: 14619521
    [Abstract] [Full Text] [Related]

  • 7. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
    Nakano H, Namatame K, Nemoto H, Motohashi H, Nishiyama K, Kumada K.
    Hepatogastroenterology; 1999 Oct; 46(28):2662-8. PubMed ID: 10522061
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
    Kosaka A, Kuzuoka M, Yamafuji K, Imaizumi A, Hattori Y, Yamashita A.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recent progress in immunopharmacology and therapeutic effects of polysaccharides.
    Chihara G.
    Dev Biol Stand; 1992 Feb; 77():191-7. PubMed ID: 1426662
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T, Tsukuda M, Inuyama Y, Taguchi T.
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [Abstract] [Full Text] [Related]

  • 17. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
    Kataoka H, Shimura T, Mizoshita T, Kubota E, Mori Y, Mizushima T, Wada T, Ogasawara N, Tanida S, Sasaki M, Togawa S, Sano H, Hirata Y, Ikai M, Mochizuki H, Seno K, Itoh S, Kawai T, Joh T.
    Hepatogastroenterology; 2009 Jun; 56(90):547-50. PubMed ID: 19579640
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunoregulatory effects of the antitumor polysaccharide lentinan on Th1/Th2 balance in patients with digestive cancers.
    Yoshino S, Tabata T, Hazama S, Iizuka N, Yamamoto K, Hirayama M, Tangoku A, Oka M.
    Anticancer Res; 2000 Jun; 20(6C):4707-11. PubMed ID: 11205205
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.